Please use this identifier to cite or link to this item:
Type: Artigo de periódico
Title: Profile Of The Use Of Disease Modifying Drugs In The Brazilian Registry Of Spondyloarthritides.
Author: Kohem, Charles L
Bortoluzzo, Adriana B
Gonçalves, Célio R
Braga da Silva, José Antonio
Ximenes, Antonio Carlos
Bértolo, Manoel B
Ribeiro, Sandra L E
Keiserman, Mauro
Menin, Rita
Skare, Thelma L
Carneiro, Sueli
Azevedo, Valderílio F
Vieira, Walber P
Albuquerque, Elisa N
Bianchi, Washington A
Bonfiglioli, Rubens
Campanholo, Cristiano
Carvalho, Hellen M S
da Costa, Izaias Pereira
Duarte, Angela L B Pinto
Leite, Nocy H
Lima, Sonia A L
Meirelles, Eduardo S
Pereira, Ivânio A
Pinheiro, Marcelo M
Polito, Elizandra
Resende, Gustavo G
Rocha, Francisco Airton C
Santiago, Mittermayer B
Sauma, Maria de Fátima L C
Valim, Valéria
Sampaio-Barros, Percival D
Abstract: Few studies have evaluated the profile of use of disease modifying drugs (DMD) in Brazilian patients with spondyloarthritis (SpA). A common research protocol was applied prospectively in 1505 patients classified as SpA by criteria of the European Spondyloarthropathies Study Group (ESSG), followed at 29 referral centers in Rheumatology in Brazil. Demographic and clinical variables were obtained and evaluated, by analyzing their correlation with the use of DMDs methotrexate (MTX) and sulfasalazine (SSZ). At least one DMD was used by 73.6% of patients: MTX by 29.2% and SSZ by 21.7%, while 22.7% used both drugs. The use of MTX was significantly associated with peripheral involvement, and SSZ was associated with axial involvement, and the two drugs were more administered, separately or in combination, in the mixed involvement (p < 0.001). The use of a DMD was significantly associated with Caucasian ethnicity (MTX , p = 0.014), inflammatory back pain (SSZ, p = 0.002) , buttock pain (SSZ, p = 0.030), neck pain (MTX, p = 0.042), arthritis of the lower limbs (MTX, p < 0.001), arthritis of the upper limbs (MTX, p < 0.001), enthesitis (p = 0.007), dactylitis (MTX, p < 0.001), inflammatory bowel disease (SSZ, p < 0.001) and nail involvement (MTX, p < 0.001). The use of at least one DMD was reported by more than 70% of patients in a large cohort of Brazilian patients with SpA, with MTX use more associated with peripheral involvement and the use of SSZ more associated with axial involvement.
Citation: Revista Brasileira De Reumatologia. v. 54, n. 1, p. 33-7
Rights: fechado
Identifier DOI: 
Date Issue: -1-Uns- -1
Appears in Collections:Unicamp - Artigos e Outros Documentos

Files in This Item:
File SizeFormat 
pmed_24878789.pdf297.74 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.